212 followers 27 articles/week
Ginkgo adds gene editing tools in buyout of Feng Zhang-founded startup

The acquisition of Proof Diagnostics, which was formed to develop a COVID-19 test, gives Ginkgo a library of novel enzymes that can be used to make genetic medicines.

Wed Feb 28, 2024 16:04
Viking data suggest obesity drug could rival Zepbound, Wegovy

The biotech’s drug led to significant weight loss in a Phase 2 trial, causing shares to double as analysts compared results to the marks set by drugs from Eli Lilly and Novo Nordisk.

Tue Feb 27, 2024 19:34
Janux shares triple on early cancer immunotherapy data

Analysts viewed results for one of Janux’s drug, a T cell engager aimed at metastatic prostate cancer, as potentially best-in-class in a field that’s crowded with competitors.

Tue Feb 27, 2024 19:34
Denali, fresh off study setback, gets $500M lift

The infusion from unnamed private investors will bolster the company’s balance sheet days after a Sanofi-partnered ALS drug stumbled in a clinical trial.

Tue Feb 27, 2024 19:13
Minerva schizophrenia drug rejected by FDA

The agency’s complete response letter knocks back Minerva’s attempt to secure approval of the drug over agency reviewers’ objections.

Tue Feb 27, 2024 18:42
Humira biosimilar from Alvotech, Teva wins FDA approval on third attempt

The companies didn’t reveal their planned price for Simlandi, which will be the 10th Humira copycat to reach the U.S. market.

Mon Feb 26, 2024 19:27

Build your own newsfeed

Ready to give it a go?
Start a 14-day trial, no credit card required.

Create account